ended3월 31일· 1 sources
동성제약, 최대주주 유암코 컨소시엄 변경…지분 72% 확보
Why it matters
Dosung Pharmaceutical undergoes major ownership restructuring as UAMCO consortium secures 72% stake through capital augmentation under rehabilitation plan. This reflects a significant shift in control to a new financial sponsor, marking a critical milestone in the company's recovery trajectory.
1
Sources
+0
24h
—
Growth
174d
Active
Dosung PharmaceuticalUAMCOShareholder restructuringPrivate equityCorporate recovery